[Exploring the Role of PCDHGB4 in the Occurrence of Lung Squamous Cell Carcinoma Based on Bioinformatics Analysis]

Ruijiao Lu1, Xieyidai Abuduhailili1, Yuxia Li1

  • 1Medical Laboratory Center, The Third Clinical Medical College (Affiliated Cancer Hospital) of
Xinjiang Medical University, Urumqi 830011, China.

Summary

Protocadherin-gamma subfamily B4 (PCDHGB4) is downregulated in lung squamous cell carcinoma (LUSC), correlating with poor prognosis. This gene impacts tumor immunity and may serve as a novel immunotherapy target for LUSC.